Corbus Pharmaceuticals Holdings, Inc. Operating Lease, Liability, Current
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Operating Lease, Liability, Current of $999.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $999.00K.
- 2026-03-31: Operating Lease, Liability, Current $1.21M.
- 2025-12-31: Operating Lease, Liability, Current $1.63M.
- 2025-09-30: Operating Lease, Liability, Current $1.74M.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $999.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.63M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.74M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.70M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.65M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.61M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $1.56M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.52M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.48M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.44M 10-K · filed 2025-03-11 | $1.44M 10-K · filed 2024-03-12 |
| 2023-09-30 | $1.40M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.36M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.32M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.28M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $1.24M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.21M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.17M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.14M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $1.10M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.07M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.04M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $972.46K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $873.52K 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $742.89K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $595.75K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $386.62K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $312.29K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $266.81K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $36.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |